Elizabeth H.z. Thompson, EVP, Head of Research & Development at ACADIA PHARMACEUTICALS INC (ACAD), sold 16,558 shares at $26.13 ($433K) on 2026-07-30, disclosed to the SEC on 2026-07-31.
Scheduled sale ($433k) by EVP, Head of Research & Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.13 | 16,508 | $431K | 99.7% |
| 2 | $26.17 | 50 | $1K | 0.3% |
| Total | $26.13 avg | 16,558 | $433K | 100% |
| Filing → |
| HZNP | SELL | 2022-07-11 | $7K | — | Filing → |
| HZNP | SELL | 2022-04-20 | $1.9M | — | Filing → |
| HZNP | SELL | 2021-08-06 | $1.6M | — | Filing → |